Clinical Trial: A Study of Avutometinib and Defactinib in People With Thyroid Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Thyroid Cancer
Study Type: INTERVENTIONAL
Official Title: Phase II of Avutometinib (VS-6766) and Defactinib In RAF Dimer-Driven RAI-Refractory Differentiated and Anaplastic Thyroid Cancer Patients
Brief Summary:
The researchers are doing this study to find out if the combination of avutometinib and defactinib is an effective treatment for RAF dimer-driven radioiodine-refractory differentiated thyroid cancer or anaplastic thyroid cancer.The researchers will also test whether avutometinib and defactinib is a safe treatment that causes few or mild side effects.
Read more